Locals need $1.2 million to save Brooklyn church after foreclosure auction
CYPRESS HILLS (PIX11) – For nearly 30 years, the Citadel Cathedral of Praise & Worship has been a 'beacon of faith, love, and hope' for its Cypress Hills community.
Now, they need $1.2 million to save it.
More Local News
Owners of the church on Barbey Street filed for Chapter 11 bankruptcy in January 2024, then the property went to a foreclosure auction in 2025, court records show.
According to a GoFundMe trying to save it, Citadel Cathedral was sold 'to the highest bidder' on April 2, leaving the community only a week to reverse the sale. So far, the GoFundMe has raised over $8,300.
'We have invested countless hours, energy, and prayers into building this church and its legacy. We cannot allow that legacy to be erased by a system that showed no mercy, even when we fought to find solutions,' wrote Jonathan Baston, the organizer of the GoFundMe.
Baston said the church was hard-hit by COVID-19, which led to a drop in attendance and decreased donations. But the church has been a community hub and a place for food drives, weddings and memorials, and more, he said.
'We know this is a huge ask—but we believe in miracles, and we believe in the power of community.' Baston wrote.
Emily Rahhal is a digital reporter who has covered New York City since 2023 after reporting in Los Angeles for years. She joined PIX11 in 2024. See more of her work here and follow her on Twitter here.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
14 minutes ago
- Yahoo
Zakai Zeigler's prelimiary injunction challenging NCAA redshirt rule for fifth year of eligibility denied
Several weeks after Zakai Zeigler filed a lawsuit against the NCAA seeking a fifth year of eligibility, his preliminary injunction has been denied, according to Yahoo Sports' Ross Dellenger. Zeigler had already played four seasons for Tennessee and didn't begin his college career until 2021, one year after the 2020-21 class that was allowed one more year of eligibility lost during the COVID-19 pandemic. Advertisement In the lawsuit, filed in the Eastern District Court of Tennessee, Zeigler was looking to play the 2025-26 season, challenging the NCAA rule that an athlete has four years of eligibility within a five-year window. Zeigler, 22, isn't allowed an opportunity to earn NIL money for a fifth year because he used up all of his eligibility. As the lawsuit argues, that deprives him of a fifth year, "the most lucrative year of the eligibility window for the vast majority of athletes." How lucrative? The lawsuit argued that Zeigler could earn between $2 million and $4 million in a fifth year based on his record of success and visibility playing in the SEC. Those figures are projections from the Spyre Sports Group, which facilitates Tennessee's NIL collective. Advertisement Athletes who receive a redshirt are allowed a fifth year of eligibility, which gives them one more year to earn NIL income. A freshman who was redshirted, for example, would still be able to earn NIL money even if he or she doesn't play. As the filing, the documents of which were posted online by Boise State professor Sam Ehrlich, reads: "Many players, however, do compete in the fifth year of their eligibility window. And they can earn NIL compensation for all five of those years. Had Zeigler been withheld from competing in sports during one of those four years, perhaps by redshirting, the NCAA rules would permit him to participate again next year. And this is true even if he would have slowed his academic progress and taken five years to graduate." Zeigler graduated in May, majoring in retail and merchandising management. This is different from the lawsuit Vanderbilt quarterback Diego Pavia filed against the NCAA, claiming that he should be allowed a fifth year of eligibility because he played his first two years for New Mexico Military Institute, a junior college. In December, Pavia was granted an injunction allowing him to play the 2025 college football season. Advertisement Last season with the Vols, the 5-foot-9 Zeigler averaged 13.6 points, 7.4 assists and 1.9 steals while shooting 32% on 122 3-point attempts. He was named a third-team All-American, and won first-team All-SEC and SEC defensive player of the year honors for two consecutive seasons. The Volunteers finished 30-8, 12-6 in the SEC, and advanced to the NCAA tournament's Elite Eight before losing to Houston. Zeigler holds the Tennessee single-season (275) and career (747) records for assists, and career steals with 251.
Forbes
28 minutes ago
- Forbes
Global Gender Gap Shrinks But Parity Is Still More Than A Century Away
The gender gap around the world is closing at its fastest pace since before the Covid-19 pandemic. But even at the current rate of progress, full parity is well over a hundred years away, new research reveals. According to the 19th edition of the World Economic Forum's annual Global Gender Gap Report, the gap across 148 economies around the world now stands at 68.8% when examining factors including economic opportunities, education, health, and political leadership. When looking at the 145 economies that were examined both this year and last, the gender gap contracted by 0.3 percentage points in 2025—from 68.4% in 2024. That marked the fastest annual contraction since before Covid-19 spread around the world in 2020, stalling or even revering progress on many metrics, such as women's labor force participation, in some countries. Despite this uptick, however, and based on the WEF's calculations, it will still take 123 years to reach full parity in gender globally, and that's assuming today's pace of progress doesn't slacken. 'The progress made in this edition was driven primarily by significant strides in political empowerment and economic participation, while educational attainment and health and survival maintained near-parity levels above 95%,' the authors of the report write. They add, however, that even though women today represent 41.2% of the global paid workforce, 'a stark leadership gap persists with women holding only 28.8% of top leadership positions.' The 2025 report showed that, while no economy has yet achieved full gender parity, some are getting closer. For a 16th consecutive year, for example, Iceland led the index with the smallest gender gap of just 92.6%. Indeed, Iceland is the only economy to have closed more than 90% of its gender gap. The country's northern European neighbors—Finland, Norway and Sweden—have all closed more than 80% of their gap and have also consistently ranked in the top 10 in every edition of the report since 2006. Other countries in this year's top 10 include the United Kingdom, the Republic of Moldova, Germany, Ireland, New Zealand and Namibia. Overall, the authors of the report note that there's a slight correlation between the current income levels of the countries covered and their gender gaps, with richer economies being marginally more gender equal. At the aggregate level, the authors note, economies considered to be high-income have closed 74.3% of their gender gap, which is slightly more than the averages observed across lower income countries. The authors emphasize, however, that this correlation 'is low and does not indicate causation.' In other words, being a high-income nation does not automatically mean that gender gaps are smaller.
Yahoo
39 minutes ago
- Yahoo
COVID-19 Vaccine Maker BioNTech Buys CureVac as It Aims for Cancer Treatments
BioNTech is buying fellow German firm CureVac for approximately $1.25 billion as the COVID-19 vaccine maker moves to expand into cancer treatments. For each CureVac share they own, investors will get about $5.46 worth of BioNTech American Depositary Shares. CureVac is developing cancer medicines using the same mRNA technology that BioNTech uses for its COVID-19 (CVAC) shares skyrocketed 37% Thursday when the biotech company agreed to be bought by COVID-19 vaccine maker and fellow German firm BioNTech (BNTX) in an all-stock deal valued at about $1.25 billion. The purchase boosts BioNTech's move into producing new cancer treatments. CureVac said its investors will receive approximately $5.46 worth of BioNTech American Depositary Shares for each CureVac share they own. That a 34% premium to yesterday's closing price. The company noted it is "developing a novel class of transformative medicines in oncology and infectious diseases based on messenger ribonucleic acid ("mRNA")." BioNTech's COVID-19 shot is also mRNA-based. BioNTech co-founder and CEO Dr. Ugur Sahin said the deal is aimed at "advancing the development of innovative and transformative cancer treatments and establishing new standards of care for various types of cancer in the coming years." The transaction is expected to close this year and would see CureVac's operating subsidiary become a wholly owned subsidiary of BioNTech. Shares of CureVac soared to their highest level since December 2023. U.S.-listed shares of BioNTech were little changed and remain down nearly 8% year-to-date. Read the original article on Investopedia 擷取數據時發生錯誤 登入存取你的投資組合 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤
